Clinical Trial Results

Showing: All studies [change]
Condition: Diabetes Location: Ogden, Utah 25 trials found
New Search
Filter
Trial Phase
Study Type
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and Impaired Renal Function on Background Dapagliflozin
PHASE3INTERVENTIONAL Sun City, Arizona +4 more
RECRUITING
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
PHASE2INTERVENTIONAL Huntsville, Alabama +4 more
RECRUITING
Efficacy and Safety of Ribupatide Administered Once Weekly in Participants Living With Obesity or Overweight and Diabetes
PHASE3INTERVENTIONAL Cullman, Alabama +4 more
RECRUITING
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Registry for Stage 2 Type 1 Diabetes
N/AOBSERVATIONAL Los Angeles, California +4 more
RECRUITING
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
PHASE1INTERVENTIONAL Miami, Florida +2 more
RECRUITING
PreventT2 Together: Examining the Efficacy of Couple-based Lifestyle Intervention to Prevent Type 2 Diabetes
NAINTERVENTIONAL Salt Lake City, Utah
RECRUITING
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
PHASE3INTERVENTIONAL Tucson, Arizona +4 more
RECRUITING
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
PHASE3INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Rezpegaldesleukin (NKTR-358) in New Onset Type 1 Diabetes Mellitus
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
Efficacy and Safety of Ribupatide in Participants Living With Obesity or Overweight With Weight-Related Comorbidities Who Do Not Have Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
PHASE3INTERVENTIONAL Anniston, Alabama +4 more
RECRUITING
Research Study on How People With Type 2 Diabetes Tolerate Switching From Semaglutide to Cagrisema
PHASE3INTERVENTIONAL Gilbert, Arizona +4 more
RECRUITING
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer
PHASE3INTERVENTIONAL Miami, Florida +4 more
RECRUITING
Circadian Intervention to Improve Cardiometabolic Health
NAINTERVENTIONAL Salt Lake City, Utah
RECRUITING
Effect of Sleep Extension on Ceramides in People With Overweight and Obesity
NAINTERVENTIONAL Salt Lake City, Utah
RECRUITING
The Acute T-Rex (Timing of Resistance Exercise) Study
NAINTERVENTIONAL Salt Lake City, Utah
RECRUITING
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
PHASE2INTERVENTIONAL Mobile, Alabama +4 more
RECRUITING
Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus
PHASE2INTERVENTIONAL Mesa, Arizona +4 more
RECRUITING
A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
PHASE3INTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
A Study to Assess the Efficacy, Safety and Tolerability of AT673 Co-administered With Semaglutide in Adult Participants With Type 2 Diabetes (T2D) and Overweight or Obesity
PHASE2INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type